Pay in 4 interest-free payments of $6.39 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
People managing diabetes should be especially cautious about medication changes
Dihexa protocols are highly individualized based on cognitive enhancement goals and response patterns
For example, in tendon fibroblast cells, BPC-157 dramatically increases phosphorylation (activation) of FAK and paxillin, leading to more cell migration and survival at injury sites
All protocols should be developed and supervised by qualified healthcare providers
Active Ingredients: per 1/2 tsp * CMD (Cell Matrix Delivery) indicates our proprietary delivery method was applied to achieve maximum ingredient absorption
Compounding BPC-157: A regulatory loophole In a statement, Health Canada said "BPC157 has not been authorized, its safety, efficacy, and quality have not been assessed and there is limited scientific evidence to support its use, including a lack of established human dosing protocols." In addition, the regulator says BPC-157 is not approved for use in any NHPs in any form, including oral and injectable, but it can still be compounded for topical use or oral administration as an NHP
US$ 26.48
US$ 25.37
US$ 26.19
US$ 29.84
